TYRUOS FINANCE
Opening research…
Retrieving research data…
Workspace/Market
TYRUOS FINANCE
88.00NOK
+3.00 (+3.53%)
Sandbox quote · 11 Sept, 14:30 UTC
Daily closing prices returned by the sandbox.
| Date | Close | Volume |
|---|---|---|
| 10 Sept 2026 | 85.20 | 9,920 |
| 7 Sept 2026 | 48.20 | 6,336 |
| 6 Sept 2026 | 41.71 | 3,370 |
| 5 Sept 2026 | 41.42 | 13,424 |
| 4 Sept 2026 | 40.70 | 9,592 |
| 3 Sept 2026 | 41.14 | 29,053 |
| 2 Sept 2026 | 43.20 | 4,950 |
| 30 Aug 2026 | 0.44 | 805,126 |
| 29 Aug 2026 | 0.45 | 1,032,035 |
| 28 Aug 2026 | 0.45 | 1,289,627 |
| 27 Aug 2026 | 0.46 | 3,528,998 |
| 26 Aug 2026 | 0.47 | 1,207,158 |
| 23 Aug 2026 | 0.47 | 530,659 |
| 22 Aug 2026 | 0.47 | 1,208,563 |
| 21 Aug 2026 | 0.48 | 2,350,862 |
| 20 Aug 2026 | 0.47 | 1,534,317 |
| 19 Aug 2026 | 0.46 | 1,368,783 |
| 16 Aug 2026 | 0.47 | 3,293,906 |
| 13 Aug 2026 | 0.49 | 5,135,595 |
| 12 Aug 2026 | 0.48 | 3,386,115 |
| 6 Aug 2026 | 0.47 | 2,671,047 |
| 5 Aug 2026 | 0.48 | 1,797,210 |
| 2 Aug 2026 | 0.47 | 2,684,794 |
| 1 Aug 2026 | 0.48 | 2,960,150 |
| 31 Jul 2026 | 0.49 | 1,270,849 |
| 30 Jul 2026 | 0.50 | 1,316,610 |
| 29 Jul 2026 | 0.48 | 3,163,101 |
| 26 Jul 2026 | 0.50 | 5,503,100 |
| 25 Jul 2026 | 0.53 | 6,245,134 |
| 24 Jul 2026 | 0.58 | 1,102,730 |
| 23 Jul 2026 | 0.59 | 1,004,918 |
| 22 Jul 2026 | 0.58 | 1,506,687 |
| 19 Jul 2026 | 0.58 | 1,082,751 |
| 18 Jul 2026 | 0.60 | 2,452,130 |
| 17 Jul 2026 | 0.53 | 1,566,569 |
| 16 Jul 2026 | 0.57 | 1,104,973 |
| 15 Jul 2026 | 0.50 | 4,653,099 |
| 12 Jul 2026 | 0.63 | 316,407 |
| 11 Jul 2026 | 0.65 | 968,661 |
| 10 Jul 2026 | 0.66 | 3,516,748 |
Sandbox observations are not verified live market data.
Historical adjustments are unverified: the sandbox returned inconsistent series for adjustment options.
Sandbox source dates can reflect replayed data and conflict with modification or original document dates.
Oncoinvent is a clinical phase radiopharmaceutical company developing treatments for solid cancers. The technology platform is focused on the use of alpha-emitting radionuclides to deliver radiation directly to cancer cells. The Company's product candidate, Radspherin®, is an alpha radiation therapy candidate designed for the local treatment of cancer that has spread to body cavities. Oncoinvent has its headquarters in Oslo.
Millistream MWS sandbox · Retrieved 11 Sept, 19:36 UTC
Market capitalisation
394.1mNOK
Sandbox quote snapshot
Day volume
11.77k
Reported traded quantity
Day range
83.20–90.00
NOK · Low to high
Previous close
85.00NOK
Provider-reported reference
What the returned data says, and what it cannot tell you. Sandbox data; every card links to its evidence.
What moved
+3.53%
Last 88.00 NOK · previous close 85.00
Volume 11.77k · market cap 394.1m
Linc AB
12.40% of capital · 12.40% of votes
Top 5 returned holders: 40.40% of capital
Data coverage